Home/Filings/4/0001209191-23-029187
4//SEC Filing

Hooper Suzanne Sawochka 4

Accession 0001209191-23-029187

CIK 0001426332other

Filed

May 11, 8:00 PM ET

Accepted

May 12, 5:51 PM ET

Size

5.7 KB

Accession

0001209191-23-029187

Insider Transaction Report

Form 4
Period: 2023-05-10
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-05-10+78,40778,407 total
    Exercise: $3.69Exp: 2033-05-09Common Stock (78,407 underlying)
Footnotes (1)
  • [F1]The stock option shall vest in four (4) approximately equal quarterly installments, such that the option shall be fully vested on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day prior to the Issuer's next annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Amended and Restated 2018 Equity Incentive Plan) on each applicable vesting date.

Issuer

NGM BIOPHARMACEUTICALS INC

CIK 0001426332

Entity typeother

Related Parties

1
  • filerCIK 0001544589

Filing Metadata

Form type
4
Filed
May 11, 8:00 PM ET
Accepted
May 12, 5:51 PM ET
Size
5.7 KB